StartseiteDokumenteImpact 2020: Advancing Massachusetts Leadership in the Life Sciences For Patients

Impact 2020: Advancing Massachusetts Leadership in the Life Sciences For Patients

Erscheinungsdatum: 03.04.2014

The Massachusetts Biotechnology Council (MassBio), the state industry association for the life sciences industry, today issued Impact 2020, a strategic report on the state of the biotechnology and life sciences cluster in Massachusetts. The extensive report issues a call to action for Massachusetts stakeholders—across industry, academia, healthcare networks, payers and government—to take steps to safeguard the Commonwealth’s definitive, but fragile, leadership position in life sciences and innovation.

MassBio’s strategic reports have been key to strengthening the regional life sciences cluster, which today is recognized as the global leader for life sciences innovation. Developed by consulting firm Health Advances through in-depth interviews of more than 100 thought leaders, Impact 2020 recommends:

  • Driving the conversation on defining value and reward for innovation in the era of outcomes-focused medicine;
  • Seizing a leadership opportunity at the intersection of IT and life sciences;
  • Evolving funding models for early stage companies and innovative ideas;
  • Improving workforce development to ensure a workforce trained for the jobs of the future and support downstream expansion; and
  • Highlighting patient stories to showcase the impact of innovation taking place in Massachusetts
Quelle: Massachusetts Biotechnology Council (MassBio) Redaktion: Länder / Organisationen: USA Themen: Netzwerke Lebenswissenschaften Wirtschaft, Märkte

Weitere Informationen